These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31540260)

  • 1. In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome.
    Piñeiro-Yáñez E; Jiménez-Santos MJ; Gómez-López G; Al-Shahrour F
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
    Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
    Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data.
    Jiménez-Santos MJ; Nogueira-Rodríguez A; Piñeiro-Yáñez E; López-Fernández H; García-Martín S; Gómez-Plana P; Reboiro-Jato M; Gómez-López G; Glez-Peña D; Al-Shahrour F
    Nucleic Acids Res; 2023 Jul; 51(W1):W411-W418. PubMed ID: 37207338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma.
    Luo S; Jia Y; Zhang Y; Zhang X
    JHEP Rep; 2023 Jun; 5(6):100754. PubMed ID: 37234275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of within-sample genetic heterogeneity from SNP-array data.
    Martinez P; Kimberley C; BirkBak NJ; Marquard A; Szallasi Z; Graham TA
    Sci Rep; 2017 Jun; 7(1):3248. PubMed ID: 28607403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
    Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
    Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview on Clinical Relevance of Intra-Tumor Heterogeneity.
    Stanta G; Bonin S
    Front Med (Lausanne); 2018; 5():85. PubMed ID: 29682505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer.
    Yang C; Zhang S; Cheng Z; Liu Z; Zhang L; Jiang K; Geng H; Qian R; Wang J; Huang X; Chen M; Li Z; Qin W; Xia Q; Kang X; Wang C; Hang H
    Genome Med; 2022 Dec; 14(1):142. PubMed ID: 36527145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study.
    Cuevas D; Velasco A; Vaquero M; Santacana M; Gatius S; Eritja N; Estaran E; Matias-Guiu X
    Histopathology; 2020 Feb; 76(3):447-460. PubMed ID: 31550396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities.
    Rubio-Perez C; Tamborero D; Schroeder MP; Antolín AA; Deu-Pons J; Perez-Llamas C; Mestres J; Gonzalez-Perez A; Lopez-Bigas N
    Cancer Cell; 2015 Mar; 27(3):382-96. PubMed ID: 25759023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.
    Khalique L; Ayhan A; Weale ME; Jacobs IJ; Ramus SJ; Gayther SA
    J Pathol; 2007 Feb; 211(3):286-95. PubMed ID: 17154249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.
    Affinito O; Orlandella FM; Luciano N; Salvatore M; Salvatore G; Franzese M
    Cancer Cell Int; 2022 Aug; 22(1):263. PubMed ID: 35996174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
    Ai H; Song D; Wang X
    Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns.
    Luo S; Zhang Y; Jia Y; Zhang X
    Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12831. PubMed ID: 35767937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer.
    Tan TZ; Heong V; Ye J; Lim D; Low J; Choolani M; Scott C; Tan DSP; Huang RY
    J Pathol; 2019 Mar; 247(3):305-319. PubMed ID: 30374975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
    Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
    Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.